未登录

M

Maria Adelaida García-Gimeno

csic - instituto de biomedicina de valencia (ibv)

H指数:23

被引数:1,937

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An astrocytic cellular model of Lafora disease to study polyglucosan accumulation and inflammation

拉福拉病的星形胶质细胞模型用于研究聚葡萄糖积累和炎症

Disease Models & Mechanisms

IF3.3

2026-01-010

OA

Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in Epm2b-Deficient Mice

腺相关病毒介导的Lafora病基因疗法在Epm2b缺陷小鼠中的应用

International Journal of Molecular Sciences 2025, Vol. 26, Page 11930

IF4.9

2025-12-110

OAAI

Aca1 and Aca2, ATF/CREB activators in Saccharomyces cerevisiae, are important for carbon source utilization but not the response to stress

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2864

OAAI

P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease

NEUROBIOLOGY OF DISEASE

IF5.6

2023-02-014

OAAI

Neuroprotective Effect of IND1316, an Indole-Based AMPK Activator, in Animal Models of Huntington Disease

ACS CHEMICAL NEUROSCIENCE

IF3.9

2021-12-285

OA

TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases

IF5.2

2021-04-0611

OAAI

Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease

IF5.1

2020-12-2312

OAAI

Oxidative Stress, a Crossroad between Rare Diseases and Neurodegeneration

IF6.6

2020-04-1546

OAAI

Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2019-06-0558

OAAI

Lafora Disease: A Ubiquitination-Related Pathology

IF5.2

2018-07-2634

OAAI

Astrocytes: new players in progressive myoclonus epilepsy of Lafora type

HUMAN MOLECULAR GENETICS

IF3.2

2018-02-0146

OAAI

An Attachment-Independent Biochemical Timer of the Spindle Assembly Checkpoint

纺锤体组装检查点的独立于附件的生化计时器

IF16.6

2017-11-0148

OAAI

The interaction between AMPKβ2 and the PP1-targeting subunit R6 is dynamically regulated by intracellular glycogen content

BIOCHEMICAL JOURNAL

IF4.3

2016-03-2910

OAAI

Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex

蛋白磷酸酶1调节亚基R6的糖原活性受laforin-malin复合物的调节

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

IF2.8

2013-07-0135

OAAI

AMPKβ subunits: more than just a scaffold in the formation of AMPK complex

IF4.2

2013-06-2449

OAAI

Glucose-dependent regulation of AMP-activated protein kinase in MIN6 beta cells is not affected by the protein kinase A pathway

IF3

2012-10-2911

PREAI

Plasmodium falciparum Inhibitor-3 Homolog Increases Protein Phosphatase Type 1 Activity and Is Essential for Parasitic Survival

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2012-01-0117

OAAI

The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 β cells

IF4.2

2010-12-0168

PREAI

Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: Lipid metabolism in cystathionine β-synthase deficiency

ATHEROSCLEROSIS

IF5.7

2010-09-0113

PREAI

Large Islets, Beta-Cell Proliferation, and a Glucokinase Mutation.

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2010-04-0882

OAAI